Verona Pharma
Pre-clinicalVerona Pharma develops novel treatments like ensifentrine in COPD. Future development is focused on chronic lung diseases such as COPD, asthma, and cystic fibrosis. Explore our advancements, patient insights, and latest investor news
Founded
2005
Focus
Small Molecules
About
Verona Pharma develops novel treatments like ensifentrine in COPD. Future development is focused on chronic lung diseases such as COPD, asthma, and cystic fibrosis. Explore our advancements, patient insights, and latest investor news
Funding History
4Total raised: $312M
PIPE$150MRTW InvestmentsJun 15, 2020
IPO$80MUndisclosedJun 15, 2018
Series B$50MOrbiMedDec 15, 2017
Series A$32MNovo HoldingsMay 15, 2016
Company Info
TypePrivate
Founded2005
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile